Quantificare

Executive Summary

Quantificare is a French medtech company established in 2003, providing standardized 2D and 3D imaging systems and services for aesthetic medicine (under Quartier Latin brand) and clinical trials (as an imaging-focused CRO). The company's core value lies in ensuring reproducibility, consistency, and objective analysis of visual data, serving aesthetic practitioners and pharmaceutical sponsors globally. With a strong foothold in Europe and expanding international reach, Quantificare benefits from the growing demand for non-invasive aesthetic procedures and the increasing reliance on imaging endpoints in dermatology and plastic surgery trials. The company's dual-market strategy diversifies revenue streams and positions it well in both high-growth sectors.

Upcoming Catalysts (preview)

• Q3 2026Expansion into new geographies for Quartier Latin brand70% success
• Q4 2026Key partnership with a top-10 pharma for a dermatology trial50% success
• Q2 2027Launch of next-generation AI-powered imaging analysis software60% success